Introduction--venous thromboembolism management in the real world: your opportunity to participate in a critical assessment.
Davidson
Bruce L
BL
Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington.
D000569:Americas / Q000453:epidemiology; D001458:Bandages; D003131:Combined Modality Therapy; D004452:Echocardiography; D005060:Europe / Q000453:epidemiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D018497:Ventricular Dysfunction, Right / Q000000981:diagnostic imaging
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight